The University of Nebraska Omaha is a public research university in Omaha, Nebraska. Founded in 1908 by faculty from the Omaha Presbyterian Theological Seminary as a private non-sectarian college, the university was originally known as the University of Omaha.

During the past decade, University of Nebraska conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 20 clinical trials were completed, i.e. on average, 34.5% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 11 clinical trials were completed. i.e. 37.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Nebraska" #1 sponsor was "University of Nebraska" with 21 trials, followed by "Celgene" with 4 trials sponsored, "Cephalon" with 4 trials sponsored, "Chimerix" with 4 trials sponsored and "CF Therapeutics Development Network Coordinating Center" with 4 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 62 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Nebraska" #1 collaborator was "Cystic Fibrosis Foundation" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "University of Nebraska" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "Blood and Marrow Transplant Clinical Trials Network" with 2 trials as a collaborator. Other collaborators include 81 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "University of Nebraska" are "Cystic Fibrosis" (5 trials), "Peripheral Arterial Disease" (5 trials), "Parkinson Disease" (3 trials), "Stroke" (3 trials) and "ADHD" (2 trials). Many other conditions were trialed in "University of Nebraska" in a lesser frequency.

Most popular intervention types in "University of Nebraska" are "Drug" (55 trials), "Device" (13 trials), "Other" (13 trials), "Biological" (10 trials) and "Dietary Supplement" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Brincidofovir" (3 trials), "Exercise" (3 trials), "Modafinil" (3 trials) and "3D Printed Upper-limb Prosthesis" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Nebraska" are 92 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 21 active trials in "University of Nebraska". 1 are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 52 completed trials in University of Nebraska, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in University of Nebraska, 6 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 24 trials that are defined as “Not Applicable".

University of Nebraska has several departments that took part in Clinical trials: "Division of Physical Therapy Education Physical Activity Lab" - 2 trials